List of Contents

Cartilage Repair Market Will Grow at CAGR of 12.13% By 2032

The global cartilage repair market size is anticipated to reach around USD 4.62 billion by 2032 up from USD 1.47 billion in 2022 with a CAGR of 12.13% Between 2023 and 2032.

Cartilage Repair Market Size and Growth Rate From 2023 To 2032

A growing elderly population, rising obesity rates, rising healthcare costs, as well as an increase in sports-related injuries are all contributing to the significant rise of the worldwide cartilage repair market. The market is also expanding as a result of a rise in cutting-edge product introductions and the expansion of medical tourism, both of which are raising awareness of cartilage treatment options throughout the world. Due to the long-term effects of this treatment, the segment for cell-based approaches is predicted to grow at the fastest rate during the forecast period.

Global makers of cartilage repair goods should benefit from the emerging nations' rapid economic expansion and the technological advancements in cartilage repair and regeneration products. The main barriers to the expansion of the worldwide market, however, are the high cost of these medications and the absence of insurance coverage for these therapies.

In the United States, obesity is a significant public health issue. The market for cartilage restoration in the United States is expanding as obesity rates rise. The CDC reports that in 2011–2012, 35.1% of adults 20 years of age or older were obese. Additionally, according to data from 2014 provided by the Organization for Economic Cooperation and Development (OECD), Germany's obesity rate rose from 11.5% in 1999 to 14.7% in 2009. The market expansion is being further accelerated by the rise in demand for liposuction operations as a result of the rising obesity rate.

Report Highlights:

  • In 2022, the fibrocartilage category accounted for a disproportionately large revenue share by application. By acting as a cushion layer in the knee joints that endure strain and stress, fibrocartilage serves as a joint stabilizer and shock absorber. Since the fibrocartilage in knee joints is much more sensitive to joint instability, it frequently serves as a warning sign of impending cartilage degeneration.
  • In 2022, the cell-based category had the highest revenue share by treatment modality. Cell-based modality is a type of biological therapy that involves replacing damaged tissues with new cells in order to cure age-related or degenerative disorders. The best tissue for regenerative purposes is cartilage. The main goal of cell-based therapy for defective cartilage is to restore damaged joint surfaces with strong tissues that can withstand the stresses and strains brought on by joint loading.
  • North America accounted for the greatest revenue share in 2022, as a result of rising obesity rates, increased usage of more sophisticated healthcare technology, rising R&D expenditures for cutting-edge cartilage repair techniques, and rising healthcare costs. Additionally, the region's market is growing in terms of revenue thanks to the existence of several significant competitors.

Cartilage Repair Market Report Scope:

Report Coverage Details
Market Revenue in 2023 USD 1.65 Billion
Projected Forecast Revenue in 2032 USD 4.62 Billion
Growth Rate from 2023 to 2032 CAGR of 12.13%
Largest Market North America
Base Year 2022
Forecast Period 2023 to 2032
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa


Regional Snapshots:

North America accounted for the largest share of the cartilage repair and regeneration market because of the high prevalence of osteoarthritis, the rising incidence of sports injuries, and increased research funding in the United States and Canada. Additionally, growing government investment in Cartilage Repair/Regeneration technologies and therapies, as well as elevated physician and patient knowledge of cutting-edge treatment procedures and technologies, are all contributing to the market's expansion in North America.

Over the course of the projection period, the Asia-Pacific region is expected to have a higher CAGR than other regions. Additionally, the increasing incidence of cartilage damage brought on by osteoporosis in Australia and New Zealand is expected to hasten the growth of the vertical. The markets in South America, the Middle East, and Africa (MEA) have been progressively growing in recent years. These markets have enormous potential since a huge number of people have ongoing joint and bone issues.

Market Dynamics:

Drivers:

The increase in joint injuries, which are mostly brought on by obesity, accidents, participating in sports, and a few other medical conditions/diseases, is what's driving the cartilage repair market's revenue rise. The number of sporting events taking place throughout the world is increasing, and younger generations are becoming more interested in sports. Knees in particular have a complicated anatomy that makes them vulnerable to injury, especially for sportsmen. Sports that put a lot of pressure on the knees, such as football, jogging, lacrosse, basketball, or skiing, raise the risk of knee injuries as a result of the severe motions involved in the sport, like sudden stops and twists and turns.

Furthermore, repeated usage of the knees when playing sports can injure the knee from blunt force trauma or rigorous training, necessitating surgery to replace the cartilage. The number of sporting events taking place throughout the world is increasing, and younger generations are becoming more interested in sports. Knees in particular have a complicated anatomy that makes them vulnerable to injury, especially for sportsmen. Sports that put a lot of pressure on the knees, such football, jogging, lacrosse, basketball, or skiing, raise the risk of knee injuries as a result of the severe motions involved in the sport, like sudden stops and twists and turns. Furthermore, repeated usage of the knees when playing sports can injure the knee from blunt force trauma or rigorous training, necessitating surgery to replace the cartilage.

Restraints:

Over the projection period, market revenue growth may be hampered by the high cost of procedures for cartilage repair. The high cost of knee cartilage repair operations may deter patients from choosing them in favor of more affordable procedures like strengthening exercises for the muscles that stabilize the knee. Additionally, a shortage of qualified surgeons who can undertake knee cartilage repair procedures may impede market revenue development.

Opportunities:

Over 1.9 billion persons aged 18 and older were estimated to be overweight in 2014, of which over 600 million adults were obese, according to the World Health Organization (WHO). In 2014, 39% of people aged 18 and older (38% of men and 40% of women) were overweight, making up around 13% of the adult population worldwide (11% of men and 15% of women). Between 1980 and 2016, the prevalence of obesity increased worldwide. Over the projected period, the market for knee cartilage repair is anticipated to benefit from the rising obesity rate.

A 2016 study found that 83% of people aged 16 and over said they exercised at least once per week, showing that the population's level of physical activity has quickly grown. Due to a lack of protective gear, the rising popularity of sports and outdoor activities has raised the risk of cartilage injuries. For the market for knee cartilage repair, this is a favorable development driver and is anticipated to fuel further expansion throughout the projected period.

Due to a busy lifestyle, the urban population engages in less physical activity and consumes unhealthy foods, which contributes to weight gain and increases the risk of injury and damage to knee cartilage. This supports the market for knee cartilage repair.

Challenge:

An extensive universal supply of progenitor cells, including embryonic stem cells and induced pluripotent stem cells for cartilage repair and regeneration, is still being actively researched. However, because to moral concerns and safety issues such immunological rejection, tumor genesis, and teratoma creation, their clinical usage is fraught with significant difficulties. Strict rules have been developed by numerous agencies to supervise these activities.

Regenerative medicine research is severely constrained in many nations throughout the world due to the existence of several authorities and ethical issues over the use of embryonic stem cells in research and development operations. Reduced potential with age and the development of fibrocartilage rather than hyaline cartilage at the site of injury are further problems with the successful utilization of stem cells.

Recent Development

  • American company Orisis Therapeutics was purchased by Smith and Nephew in 2019. The company's client base expanded as a result of this purchase, which also improved Smith and Nephew's advanced wound care management segment.
  • Innovative Cellular Therapeutics and Vericel Corporation cooperated in 2018 to develop and market MACI, Ixmyelocel-T, and Carticel medicines in several Asian nations, including Singapore, China, South Korea, and others.

Key Market Players:

  • Smith+ Nephew
  • Stryker
  • Zimmer Biomet
  • B. Braun Melsungen AG
  • The Future of Biotechnology
  • MEDIPOST
  • Vericel Corporation,
  • CONMED Corporation
  • Medical Devices Business Services (DePuy Synthes)
  • Meril Life Sciences Pvt. Ltd.
  • Arthrex, Inc.
  • Medacta International
  • Teijin Nakashima Medical Co., Ltd.
  • BioTissue SA
  • ISTO Technologies, Inc.
  • CartiHeal, Inc.
  • Mathys AG Bettlach
  • Waldemar Link GmbH & Co.KG
  • JRI Orthopaedics
  • Regentis Biomaterials Ltd.
  • Auxein Medical.
  • EVOLUTIS INDIA PVT. LTD.
  • Japan MDM, Inc.

Segments Covered in the Report

By Type

  • Cell-Based
  • Chondrocyte Transplantation
  • Growth Factor Technology
  • Non-Cell-Based
  • Tissue Scaffolds
  • Cell-Free Composites

By Application

  • Hyaline
  • Fibrocartilage

By Treatment Type

  • Palliative
  • Viscosupplementation
  • Debridement & Lavage
  • Intrinsic Repair Stimulus

By Site

  • Knee Cartilage Repair
    • Arthroscopic Chondroplasty
    • Autologous Chondrocyte
    • Osteochondral Grafts Transplantation
    • Cell-based Cartilage Resurfacing
    • Microfracture
    • Other
  • Other

Buy this Research Report@ https://www.precedenceresearch.com/checkout/2573

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 9197 992 333